Completed
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
NCT00134147
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Washington D.C., District of Columbia, United States
- Pfizer Investigational Site Jacksonville, Florida, United States